Percutaneous Coronary Intervention (PCI)
Cardiovascular
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| prasugrel | Mylan II B.V. (MYL) |
Phase 3(1)
| Drug | Company |
|---|---|
| angiomax | SCICLONE PHARMACEUTICALS INC (SCLN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Percutaneous Coronary Intervention (PCI)?
BioSniper tracks 2 drugs in development for Percutaneous Coronary Intervention (PCI) across 2 companies.
How many clinical trials target Percutaneous Coronary Intervention (PCI)?
There are 1 clinical trial targeting Percutaneous Coronary Intervention (PCI) tracked by BioSniper.
Deep-dive into Percutaneous Coronary Intervention (PCI)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis